GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neovacs SA (XPAR:ALNEV) » Definitions » Other Gross PPE

Neovacs (XPAR:ALNEV) Other Gross PPE : €1.40 Mil (As of Jun. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Neovacs Other Gross PPE?

Neovacs's Other Gross PPE for the quarter that ended in Jun. 2024 was €1.40 Mil.

Neovacs's quarterly Other Gross PPE increased from Jun. 2023 (€0.19 Mil) to Dec. 2023 (€0.20 Mil) and increased from Dec. 2023 (€0.20 Mil) to Jun. 2024 (€1.40 Mil).

Neovacs's annual Other Gross PPE increased from Dec. 2021 (€0.10 Mil) to Dec. 2022 (€0.12 Mil) and increased from Dec. 2022 (€0.12 Mil) to Dec. 2023 (€0.20 Mil).


Neovacs Other Gross PPE Historical Data

The historical data trend for Neovacs's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neovacs Other Gross PPE Chart

Neovacs Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.13 0.10 0.12 0.20

Neovacs Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.12 0.19 0.20 1.40

Neovacs Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Neovacs Business Description

Traded in Other Exchanges
Address
3-5, Impasse Reille, Paris, FRA, 75014
Neovacs SA is a biotechnology company focused on the development of "Kinoids", therapeutic vaccines for the treatment of autoimmune, inflammatory diseases, allergies and cancer.

Neovacs Headlines

No Headlines